Lymphatic disorders caused by mosaic, activating KRAS variants respond to MEK inhibition

Sarah E. Sheppard(Children's Hospital of Philadelphia), Håkon Håkonarson(Children's Hospital of Philadelphia), Ian D. Krantz(Northwell Health), Nahla Khalek(Children's Hospital of Philadelphia), Jessenia Guerrero, Pablo Laje(Children's Hospital of Philadelphia), Christopher L. Smith(Children's Hospital of Philadelphia), Michael March(Children's Hospital of Philadelphia), Leticia S. Matsuoka(Children's Hospital of Philadelphia), Victoria R. Sanders, Cuiping Hou(Children's Hospital of Philadelphia), Kristen Snyder(Children's Hospital of Philadelphia), Joseph T.C. Shieh(University of California, San Francisco), Lea F. Surrey(Children's Hospital of Philadelphia), Thy Huynh(Northwestern University), Ilona J. Frieden(University of California, San Francisco), Adam I. Rubin(NYU Langone Health), Jessica Priestley, Diana J. Slater(Genomics (United Kingdom)), Taizo A. Nakano(Children's Hospital Colorado), Nora O’Connor(Children's Hospital of Philadelphia), Christoph Seiler(Children's Hospital of Philadelphia), Yoav Dori(Institute of Cardiology), Arupa Ganguly(University of Pennsylvania), Erin Pinto(Children's Hospital of Philadelphia), Leslie Castelo‐Soccio(National Institutes of Health), David M. Biko(Children's Hospital of Philadelphia), Dong Li(Children's Hospital of Philadelphia), Erica Schindewolf(Children's Hospital of Philadelphia), Rojeen Niazi(University of Pennsylvania), S Kim(Genomics (United Kingdom)), Charlly Kao(Children's Hospital of Philadelphia), Mark R. Battig(Children's Hospital of Philadelphia)
JCI Insight
May 7, 2023
Cited by 37


Related Papers